Teva Pharmaceutical Industries Limited
$41.10B- Market cap
- $42.84B
- Debt
- +$1.82B
- Cash
- −$3.56B
Capital structure 96% equity / 4% debt · EV / Revenue 2.38x · EV / EBITDA 10.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
TEVA · price snapshotP/E 30.38x
$36.76Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at PANW's multiple
$254.84593.3% above market
1.21 TEVA Annual EPS×210.61x PANW P/E=$254.84
Market $36.76Implied $254.84
PANW · price snapshotP/E 210.61x
$336.98Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at TEVA's multiple
$48.6185.6% below market
1.60 PANW Annual EPS×30.38x TEVA P/E=$48.61
Market $336.98Implied $48.61